Quickly verify claims by accessing the underlying experimental data and figures.
Press Enter ↵ to solve
Fuel Your Discoveries
"Biology gives you a brain. Life turns it into a mind."
- Jeffrey Eugenides
Quick Explanation
Copied
Core takeaway
The paper builds a multi-omics “atlas” of what ferroptotic cells release (proteins, oxylipins, metabolites) and then links the ferroptosis-associated secretome—especially an EV-containing fraction—to TLR-dependent macrophage priming and enhanced LPS-driven TNF/IL-6 responses in vitro, while arguing this differs from necroptosis-associated secretomes.
Evidence is grounded in the authors’ multi-omics quantification and functional macrophage assays.
Long Explanation
Paper Review (Raw-text basis)
Title: An atlas of ferroptosis-induced secretomes
()
Published: 25 April 2025.
Main biological claim evaluated: ferroptosis releases a distinct secretome that primes macrophages via TLR-dependent sensing and enhances subsequent LPS-driven cytokine output.
What this review does
Visualize the paper’s core secretome outputs and workflow.
Critically check evidential strength and pinpoint plausible blind spots (e.g., MS sensitivity/EV fraction purity/timing).
Extract mechanistic inferences that are explicitly supported vs those that remain plausible but not proven.
Figure-style overview: “what goes into the atlas”
Secretome components quantified
The authors quantify: (1) secreted proteins (total secretome proteomics by SILAC), (2) newly translated secretome proteins (AHA/HILAQ click-chemistry capture), (3) oxylipins (targeted LC-MS/MS panel), and (4) metabolites (targeted metabolomics via LC-MS/MS).
Values are taken directly from the authors’ reported protein set sizes.
Timeline visualization: early ATP vs late permeabilization-associated factors
The paper proposes a staged release pattern during ferroptosis: early release of nucleotides (ATP), intermediate release of factors such as MIF and metabolic subsets, and late release accompanying near-complete permeabilization, including LDH and prostaglandins.
⚠️ This plot encodes only a qualitative “stage presence” interpretation from the authors’ described timeline, not measured concentrations across stages. The underlying staged narrative is supported by the manuscript’s timing schematic.
Functional claims: macrophage priming and TLR-dependence
The central functional observation is that ferroptotic supernatants induce a macrophage transcriptional program consistent with priming (e.g., Il1b mRNA upregulation) and then enhance cytokine secretion after subsequent IFN-γ/LPS stimulation.
The paper further reports that priming requires TLR2/4/9 and adapter proteins (MyD88/TRIF), as the transcriptional induction is “completely abrogated” in selected deficient macrophage genotypes.
EV involvement is supported by experiments where EV depletion attenuates (but does not fully eliminate) priming activity.
Evidence strength map (what is strongly supported vs inferential)
Strongly supported by direct measurements: ferroptosis-conditional release differences in proteins/oxylipins/metabolites and functional priming phenotypes in macrophage cultures.
Moderately supported mechanistic linkage: EV-containing fraction contributes to priming, but “partial loss” suggests multiple factors/classes may act together.
Speculative / not fully resolved: which specific secreted molecules within EVs are the primary TLR ligands (beyond the requirement for TLR2/4/9 and adapter proteins). The paper indicates uncertainty that multiple classes (oxylipins/metabolites/EV cargo) may contribute, and that extensive future work is needed to narrow down mediators.
Critical appraisal (skeptical review)
1) Proteomics sensitivity vs “absence of evidence”
The authors report that chemo-cytokines known to be released in other regulated death contexts were not detected by MS, while ELISA revealed CXCL1 constitutive release (unchanged by ferroptosis).
This is a defensible interpretive caution, but a general limitation remains: the proteomics panel’s detection threshold and peptide coverage biases can make “no detection” hard to interpret as “no biology”. (The authors partially acknowledge this in the Discussion.)
2) EV fraction purity and interpretability
EV depletion is a central mechanistic lever; however, EV separation by ultracentrifugation/centrifugation can leave incompletely separated vesicle populations or co-pellet protein aggregates. The authors indicate that boiled “cooked” supernatants retain priming (heat-stable component) and that EV depletion leads to partial attenuation rather than abolition.
Therefore, the “EVs are responsible” hypothesis is not fully proven; it is better framed as “EVs contribute and interact with other soluble/vesicular mediators”.
3) TLR dependence establishes pathway requirement, not ligand identity
The dependence on TLR2/4/9 and MyD88/TRIF is strong evidence that the macrophage response is initiated via this innate pathway architecture.
However, because TLR ligand classes are diverse, the specific upstream priming ligand(s) remain unidentified within this paper; the authors themselves emphasize uncertainty and future work needed to narrow mediator classes (e.g., metabolites, oxylipins, EV-borne oxidized lipids).
The study uses specific ferroptosis induction strategies (e.g., GPX4 deletion) and compares to necroptosis contexts.
Differences in stimulus triggers (e.g., whether TNF is present) can change secretome composition in general. The paper partially addresses this by distinguishing TNF-dependent vs -independent necroptosis and by probing NF-κB activation conditions.
Still, generalizing from these in vitro systems to in vivo tissue ferroptosis likely requires additional validation across cell types and physiological contexts (the paper itself positions this as an initial atlas / basis for future studies).
Decision-oriented synthesis
What you can take to the bench: ferroptosis supernatants can function as priming agents for macrophages, shifting the response magnitude upon a second innate stimulus (IFN-γ/LPS), with pathway dependence on TLR2/4/9 and MyD88/TRIF.
What remains unresolved: the “active ingredient(s)” are not pinpointed to a single molecule class; EVs contribute but partial attenuation suggests either incomplete depletion or synergy among multiple components.
Most testable mechanistic inference: “TLR-mediated DAMP sensing is required to initiate the transcriptional priming program.”
Author-review shortcuts (click to go deeper in BGPT)
Feedback:
Updated: March 24, 2026
BGPT Paper Review
Study Novelty
90%
The work claims a “first atlas” integrating multiple secretome modalities (proteomics, newly translated proteins, targeted oxylipins, and metabolomics) for ferroptosis and then connects that catalog to a defined immune function (macrophage priming) with TLR-pathway dependence—an unusually comprehensive coupling of cataloging + functional mechanism for ferroptosis secretomes.
Scientific Quality
90%
Scientific quality is high: clear mechanistic contrasts (ferroptosis vs necroptosis contexts), multiple orthogonal omics layers, and pathway-dependent macrophage functional assays (TLR2/4/9 and MyD88/TRIF). Main skeptical points are interpretability limits inherent to secretome quantification (non-targeted proteomics sensitivity, partial EV depletion effects, and lack of identification of the specific priming ligand(s)).
Study Generality
80%
The findings are likely broadly relevant as a framework (how to map regulated cell death secretomes and test immune pathway dependence), but generalization to all ferroptosis triggers, cell types, and in vivo tissue contexts is not guaranteed because the atlas is constructed using specific mouse cell models and specific induction strategies.
Study Usefulness
90%
As a resource, the integrated secretome atlas plus experimentally tested priming readout (TLR-mediated macrophage priming and augmented TNF/IL-6 after IFN-γ/LPS) is directly useful for hypothesis generation about immune modulation by ferroptosis.
Study Reproducibility
80%
Methods are described in substantial detail (SILAC workflow, click chemistry capture, targeted oxylipins, targeted metabolomics, RNA-seq pipeline parameters, statistical approaches). Remaining reproducibility risks are typical for secretome/EV fractionation (sample handling, EV depletion purity, and MS coverage variability), and the paper notes that the authors did not report original code.
Explanatory Depth
90%
The paper goes beyond cataloging by proposing a staged release model and by testing pathway dependence (TLR2/4/9/MyD88/TRIF) for macrophage transcriptional priming, then demonstrating a functional “primed hyper-response” under LPS/IFN-γ re-stimulation. The remaining unresolved piece is identification of the specific priming mediators among EV cargo/soluble metabolite/oxylipin classes.
It parses the supplementary secretome tables (S1–S6), builds ranked feature lists (proteins/oxylipins/metabolites), then computes overlap enrichment across classes and correlates with priming-relevant TLR pathway annotations from the paper.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The idea that ferroptosis primarily drives macrophage priming via a single, newly translated soluble cytokine burst is weaker because the study reports limited detection of chemo-/cytokines in non-targeted MS and shows priming persists after boiling (consistent with vesicular/heat-stable contributions) and is TLR-pathway dependent.
A pure necroptosis-style DAMP release model (e.g., primarily TNF/MLKL-driven cytokine synthesis) is less explanatory because the paper distinguishes ferroptosis from necroptosis in priming ability and in chemokine release patterns (e.g., CXCL1/2 induction differences).
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Fuel Your Discoveries
Ask a Follow-Up
Key Insight
Keep Exploring
